CareToLive Reports: The FDA Fiddles While 30,00... ( DUBLIN Ohio Nov. 26 /- /CTL/ -- C...)

CareToLive Reports: The FDA Fiddles While 30,000 Men Burn

Date:11/26/2007

DUBLIN, Ohio, Nov. 26 /PRNewswire/ -- /CTL/ -- CareToLive, a not for profit corporation, received a set back in a lower Federal Court last Wednesday in its fight against the FDA on behalf of terminal cancer patients. Undeterred, they announced that they will immediately file an appeal in the 6th Circuit Court in Ohio.

"Men are dying while a safe, effective treatment languishes outside of their grasp," said CareToLive spokesperson, Melody Davis. "Congress needs to wake up and hold hearings immediately! We are going to intensify our advocacy efforts on behalf of cancer patients. We feel the real reasons for the delay were financial and political conflicts. The FDA continues to ignore the cries of the 30,000 men dying of prostate cancer each year, and refuses to protect their health and well being as they are sworn to do."

"The evidence clearly shows our government violated these men's right to live," said Mike Kearney, a CareToLive board member. "They can say it, explain it, and infer it any way they want, but the truth is they allowed over 16,000 men to die since May 8th without treatment, while other men profited handsomely during their demise."

There has been only one approved treatment for late stage prostate cancer in over 42 years. The FDA decision was unprecedented in a late stage disease where the FDA special Advisory Panel of experts voted overwhelmingly that Provenge is safe and effective and no viable alternatives exist. Financially conflicted panel members, after failing to sabotage Provenge during the advisory meeting, "leaked" letters fraught with misinformation to improperly lobby FDA decision-makers and place public pressure on those decision-makers.

"The FDA makes up its rules as it goes along," Mr. Kearney continued, "and it does not follow its own rules, ignores congressional mandates and apparently answers to no one. The lower court indicated that the case is not reviewable as the FDA has not yet made a final deci
'/>"/>

2

GOOD

Page: 1 2 3
Related medicine news :

1. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
2. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
3. J.D. Power and Associates Reports: Rush-Copley Medical Center Recognized for Third Consecutive Year for Providing an Outstanding Inpatient Experience
4. Another Reason Not to Smoke While Pregnant: Birth Defects
5. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
6. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
7. Mecklenburg EMS Agency Launches Innovative Program to Pay Future EMTs While They Train
8. Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy
9. Chronic kidney disease rises while most people with the condition remain unaware
10. 1 in 5 young Britons has sex with someone new while abroad
11. GNC Joins St. Jude Childrens Research Hospital(R) to Kick Off Fourth Annual Thanks And Giving(R) Campaign, Asking America to Help Save Childrens Lives While Shopping for the Holidays

Post Your Comments:

CareToLive Reports: The FDA Fiddles While 30,00...( DUBLIN Ohio Nov. 26 /- /CTL/ -- C...),Health